Improved Outcomes with Linezolid for Methicillin-Resistant Staphylococcus aureus Infections: Better Drug or Reduced Vancomycin Susceptibility?

Gelijkaardige items

• Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
  door: Howden, Benjamin P., et al.
  Gepubliceerd in: (2010)
• 1588. Delafloxacin Activity Against Staphylococcus aureus with Reduced Susceptibility or Resistance to Methicillin, Vancomycin, Daptomycin, or Linezolid
  door: Saravolatz, Louis D, et al.
  Gepubliceerd in: (2019)
• Prospective Comparison of the Clinical Impacts of Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Susceptible MRSA
  door: Horne, K. C., et al.
  Gepubliceerd in: (2009)
• Methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in Taiwan
  door: Lin, Chien-Yu, et al.
  Gepubliceerd in: (2018)
• Reduced Susceptibility to Vancomycin in Staphylococcus aureus
  door: Mimica, Marcelo J.
  Gepubliceerd in: (2011)